Wandercraft, the global leader in self-balancing robotic mobility systems, announced yesterday that it has secured $75 million as part of its Series D round, with major contributions from Renault Group; the PSIM fund, managed on behalf of the French state by Bpifrance as part of the France 2030 plan; Teampact Ventures; and Quadrant Management. This influx of capital arrives during a time of rapid growth, increased global visibility and product innovation in clinical, consumer and industrial robotics.
The new funding will help propel Wandercraft into its next phase of growth: bringing Eve, the world’s first self-balancing personal exoskeleton, to market as early as 2026; expanding clinical adoption of its flagship rehabilitation system, Atalante X; and developing and deploying Calvin-40, its humanoid robot.
“The momentum we’ve achieved over the past few years is extraordinary,” said Matthieu Masselin, CEO and co-founder of Wandercraft. “We’ve expanded globally; launched pivotal clinical trials; readied the commercialization of Eve, our personal exoskeleton; and entered a landmark partnership with Renault. This funding allows us to continue our mission of transforming how people live, move and work across rehabilitation and home environments and, soon, on factory floors.”
The news comes off the back of Wandercraft’s announcement with Renault Group, whereby the car manufacturer now has a minority-stake ownership and a strategic partnership with Wandercraft. The partnership brings Renault Group’s industrial expertise to scale up production of Wandercraft’s exoskeletons and industrial robots. Renault is Wandercraft’s first commercial partner and customer of Calvin-40, named for its development time of just 40 days.
Calvin-40 is an industrial-grade robot intended for physically demanding tasks and the first humanoid robot developed by a European company. Calvin-40’s rapid development was made possible by using Wandercraft’s rapid development process and existing leading-edge robotics platform integrated with NVIDIA Isaac technologies, including the NVIDIA Isaac GR00T N1 foundation model and the NVIDIA Jetson edge AI platform.
Looking ahead, the Series D funding will accelerate:
- Commercial deployment of Eve, the personal exoskeleton, in home and outdoor environments
- A new phase of growth and support for Atalante X
- Industrial development and rollout of Calvin-40 and the broader Calvin humanoid family
Paul-François Fournier, executive director of Bpifrance Innovation, said, “We are delighted to renew our support for Wandercraft, which has been supported by Bpifrance since 2017. This D series alongside Renault Group will enable the company to accelerate the industrial deployment of its unique robotics technology and make the Eve exoskeleton accessible to as many people as possible. Access to health and mobility for all is indeed a strategic focus of Bpifrance and France 2030.”
Today’s news follows a period of major growth since the company raised its Series C round of $45 million, led by Quadrant Management, which fueled U.S. commercial expansion and helped drive a tenfold increase in revenues. Other participants in the Series D round include LBO France, Mutuelles Impact – Managed by XAnge, Cemag Invest, Martagon Capital and AG2R LA MONDIALE.
link